HomeEverythingEducation
Equities & FundsCrypto & Digital AssetsAI & TechnologyBusiness & CorporateUS Politics & PolicyGeopolitics & Global RiskMacro, Rates & FXCommodities & EnergyEuropean Politics & MarketsAsia-PacificReal Estate & Property
Story archiveAll categories
← All Stories

McKesson Unit Prices $2.25 Billion Leveraged Loan Ahead of IPO

Created at 3 Jun · 11:10 PM1 source↑ Market-relevant
IN SHORT

McKesson Corp.'s medical-surgical unit priced a $2.25 billion leveraged loan on Wednesday. This comes ahead of the unit's planned initial public offering.

✉Newsletter

PiQ Daily

Pick your topics. Get only what matters, on your cadence.

Key Numbers

$2.25 billionleveraged loan size

Who's Involved

McKesson Corp.
parent company of the medical-surgical unit
McKesson Unit Prices $2.25 Billion Leveraged Loan Ahead of IPO

↳ Why This Matters

The pricing of a large leveraged loan ahead of an IPO can signal investor appetite and provide capital for the newly independent entity, potentially impacting the success of the upcoming stock offering.

Key facts

  • McKesson Corp.'s medical-surgical unit priced a $2.25 billion leveraged loan.
  • The loan was priced on Wednesday.
  • The unit is planning an initial public offering.

McKesson Corp.'s medical-surgical unit has priced a $2.25 billion leveraged loan. The pricing of the loan occurred on Wednesday. This financial move precedes the unit's anticipated initial public offering (IPO). The details suggest a significant financial maneuver by McKesson as it prepares to spin off and list its medical-surgical division.

Frequently asked questions

A leveraged loan is a type of loan extended to companies that already have a significant amount of debt. These loans typically carry higher interest rates due to the increased risk.

An IPO is the process by which a private company first sells shares of stock to the public, becoming a publicly traded company.

McKesson Corp. is a global healthcare company that distributes pharmaceuticals and medical supplies, and provides health information technology, services, and care management.

What Happens Next

01The medical-surgical unit is expected to proceed with its initial public offering.

Get the newsletter.

Pick the topics you actually care about. We'll email when there's news worth your time, on the cadence you choose. Cancel any time from your account.

Cadence
CME Headlines
  • New Product Summary: Initial Listing of Fifty-Five (55) Single Stock Futures Contracts — Effective July 27, 2026
    27 Jul · 4:32 PM
  • New Product Summary: Initial Listing of Twenty-Two (22) Micro Single Stock Futures Contracts - Effective July 27, 2026
    27 Jul · 4:11 PM
  • Initial Listing of Additional Event Contract Swaps on Pro Golf Tournaments
    9 Jul · 9:41 AM

How It Developed

3 Jun · 10:54 PM
McKesson Corp.'s medical-surgical unit priced a $2.25 billion leveraged loan on Wednesday before its planned IPO.
Bloomberg | Markets via PiQSuite

Sources

T1
McKesson Unit Prices $2.25 Billion Leveraged Loan Ahead of IPOm.piqsuite.com

Related Stories

SK Hynix $28B ADR bookbuild closes Wednesday amid strong demand
8 Jul · 7:57 AM
JPMorgan Hires Michael Flynn to Lead New Small-Cap Banking Business
8 Jul · 3:03 PM
Morgan Stanley manager flags AI debt concerns for Big Tech
8 Jul · 7:15 PM
SK Group chief to attend SK hynix ADR listing debut on Nasdaq
8 Jul · 11:55 PM
Goldman Sachs sees buyout opportunities in Japan, South Korea, Australia
9 Jul · 4:19 AM